-
1
-
-
0001137924
-
Communication, organization, and crisis
-
Seeger MW, Sellnow TL, Ulmer RR. Communication, organization, and crisis. Communication Yearbook 1998; 21:231-275.
-
(1998)
Communication Yearbook
, vol.21
, pp. 231-275
-
-
Seeger, M.W.1
Sellnow, T.L.2
Ulmer, R.R.3
-
2
-
-
84884667099
-
High-density lipoproteins. Multifunctional but vulnerable protections from atherosclerosis
-
Annema W, von Eckardstein A. High-density lipoproteins. Multifunctional but vulnerable protections from atherosclerosis. Circ J 2013; 77:2432-2448.
-
(2013)
Circ J
, vol.77
, pp. 2432-2448
-
-
Annema, W.1
Von Eckardstein, A.2
-
3
-
-
70450081001
-
Major lipids, apolipoproteins, and risk of vascular disease
-
Emerging Risk Factors Collaboration. Di Angelantonio E, Sarwar N, et al. Major lipids, apolipoproteins, and risk of vascular disease. JAMA 2009; 302:1993-2000.
-
(2009)
JAMA
, vol.302
, pp. 1993-2000
-
-
Di Angelantonio, E.1
Sarwar, N.2
-
4
-
-
84885022632
-
Levels and changes of HDL cholesterol and apolipoprotein A-I in relation to risk of cardiovascular events among statin-treated patients: A meta-analysis
-
Boekholdt SM, Arsenault BJ, Hovingh GK, et al. Levels and changes of HDL cholesterol and apolipoprotein A-I in relation to risk of cardiovascular events among statin-treated patients: a meta-analysis. Circulation 2013; 128:1504-1512.
-
(2013)
Circulation
, vol.128
, pp. 1504-1512
-
-
Boekholdt, S.M.1
Arsenault, B.J.2
Hovingh, G.K.3
-
5
-
-
84904490497
-
Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: Meta-analysis of randomised controlled trials including 117 411 patients
-
Keene D, Price C, Shun-Shin MJ, Francis DP. Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117 411 patients. BMJ 2014; 349:g4379.
-
(2014)
BMJ
, vol.349
, pp. g4379
-
-
Keene, D.1
Price, C.2
Shun-Shin, M.J.3
Francis, D.P.4
-
6
-
-
84905658469
-
Mendelian randomization studies in coronary artery disease
-
Jansen H, Samani NJ, Schunkert H. Mendelian randomization studies in coronary artery disease. Eur Heart J 2014; 35:1917-1924.
-
(2014)
Eur Heart J
, vol.35
, pp. 1917-1924
-
-
Jansen, H.1
Samani, N.J.2
Schunkert, H.3
-
7
-
-
84919608591
-
Effects of established hypolipidemic drugs on HDL concentration, subclass distribution, and function
-
Gomaraschi M, Adorni MP, Banach M, et al. Effects of established hypolipidemic drugs on HDL concentration, subclass distribution, and function. Handb Exp Pharmacol 2015; 224:593-615.
-
(2015)
Handb Exp Pharmacol
, vol.224
, pp. 593-615
-
-
Gomaraschi, M.1
Adorni, M.P.2
Banach, M.3
-
8
-
-
84988715284
-
Cholesterol efflux capacity, macrophage reverse cholesterol transport and cardioprotective HDL
-
Hutchins PM, Heinecke JW. Cholesterol efflux capacity, macrophage reverse cholesterol transport and cardioprotective HDL. Curr Opin Lipidol 2015; 26:388-393.
-
(2015)
Curr Opin Lipidol
, vol.26
, pp. 388-393
-
-
Hutchins, P.M.1
Heinecke, J.W.2
-
9
-
-
84930741855
-
HDL particle size is a critical determinant of ABCA1-mediated macrophage cellular cholesterol export
-
Du XM, Kim MJ, Hou L, et al. HDL particle size is a critical determinant of ABCA1-mediated macrophage cellular cholesterol export. Circ Res 2015; 116:1133-1142.
-
(2015)
Circ Res
, vol.116
, pp. 1133-1142
-
-
Du, X.M.1
Kim, M.J.2
Hou, L.3
-
10
-
-
84923046255
-
Cholesterol, inflammation and innate immunity
-
Tall AR, Yvan-Charvet L. Cholesterol, inflammation and innate immunity. Nat Rev Immunol 2015; 15:104-116.
-
(2015)
Nat Rev Immunol
, vol.15
, pp. 104-116
-
-
Tall, A.R.1
Yvan-Charvet, L.2
-
11
-
-
84901921079
-
Pro-resolving lipid mediators are leads for resolution physiology
-
Serhan CN. Pro-resolving lipid mediators are leads for resolution physiology. Nature 2014; 510:92-101.
-
(2014)
Nature
, vol.510
, pp. 92-101
-
-
Serhan, C.N.1
-
12
-
-
84954374265
-
Dietary cholesterol effects on adipose tissue inflammation
-
Chung S, Parks JS. Dietary cholesterol effects on adipose tissue inflammation. Curr Opin Lipidol 2016; 27:19-25.
-
(2016)
Curr Opin Lipidol
, vol.27
, pp. 19-25
-
-
Chung, S.1
Parks, J.S.2
-
13
-
-
84883198250
-
Regulation of signal transduction by HDL
-
Mineo C, Shaul PW. Regulation of signal transduction by HDL. J Lipid Res 2013; 54:2315-2324.
-
(2013)
J Lipid Res
, vol.54
, pp. 2315-2324
-
-
Mineo, C.1
Shaul, P.W.2
-
14
-
-
84919663377
-
Signal transduction by HDL: Agonists, receptors, and signalling cascades
-
Nofer JR. Signal transduction by HDL: agonists, receptors, and signalling cascades. Handb Exp Pharmacol 2015; 224:229-256.
-
(2015)
Handb Exp Pharmacol
, vol.224
, pp. 229-256
-
-
Nofer, J.R.1
-
15
-
-
84937417075
-
HDL-bound sphingosine-1-phosphate restrains lymphopoiesis and neuroinflammation
-
Blaho VA, Galvani S, Engelbrecht E, et al. HDL-bound sphingosine-1-phosphate restrains lymphopoiesis and neuroinflammation. Nature 2015; 523:342-346.
-
(2015)
Nature
, vol.523
, pp. 342-346
-
-
Blaho, V.A.1
Galvani, S.2
Engelbrecht, E.3
-
16
-
-
84892907535
-
High-density lipoprotein: Vascular protective effects, dysfunction, and potential as therapeutic target
-
Lüscher TF, Landmesser U, von Eckardstein A, Fogelman AM. High-density lipoprotein: vascular protective effects, dysfunction, and potential as therapeutic target. Circ Res 2014; 114:171-182.
-
(2014)
Circ Res
, vol.114
, pp. 171-182
-
-
Lüscher, T.F.1
Landmesser, U.2
Von Eckardstein, A.3
Fogelman, A.M.4
-
17
-
-
84947213758
-
HDL and glucose metabolism: Current evidence and therapeutic potential
-
Siebel AL, Heywood SE, Kingwell BA. HDL and glucose metabolism: current evidence and therapeutic potential. Front Pharmacol 2015; 6:258.
-
(2015)
Front Pharmacol
, vol.6
, pp. 258
-
-
Siebel, A.L.1
Heywood, S.E.2
Kingwell, B.A.3
-
18
-
-
84954390868
-
Apolipoprotein A-I interactions with insulin secretion and production
-
Rye KA, Barter PJ, Cochran BJ. Apolipoprotein A-I interactions with insulin secretion and production. Curr Opin Lipidol 2016; 27:8-13.
-
(2016)
Curr Opin Lipidol
, vol.27
, pp. 8-13
-
-
Rye, K.A.1
Barter, P.J.2
Cochran, B.J.3
-
19
-
-
84929089050
-
The role of high-density lipoproteins in the regulation of angiogenesis
-
Tan JT, Ng MK, Bursill CA. The role of high-density lipoproteins in the regulation of angiogenesis. Cardiovasc Res 2015; 106:184-193.
-
(2015)
Cardiovasc Res
, vol.106
, pp. 184-193
-
-
Tan, J.T.1
Ng, M.K.2
Bursill, C.A.3
-
21
-
-
84926293921
-
Emerging biology of sphingosine-1-phosphate: Its role in pathogenesis and therapy
-
Proia RL, Hla T. Emerging biology of sphingosine-1-phosphate: its role in pathogenesis and therapy. J Clin Invest 2015; 125:1379-1387.
-
(2015)
J Clin Invest
, vol.125
, pp. 1379-1387
-
-
Proia, R.L.1
Hla, T.2
-
22
-
-
84939201829
-
HDL-bound sphingosine 1-phosphate acts as a biased agonist for the endothelial cell receptor S1P1 to limit vascular inflammation
-
Galvani S, Sanson M, Blaho VA, et al. HDL-bound sphingosine 1-phosphate acts as a biased agonist for the endothelial cell receptor S1P1 to limit vascular inflammation. Sci Signal 2015; 8:ra79.
-
(2015)
Sci Signal
, vol.8
, pp. ra79
-
-
Galvani, S.1
Sanson, M.2
Blaho, V.A.3
-
23
-
-
84924975762
-
Improving reconstituted HDL composition for efficient postischemic reduction of ischemia reperfusion injury
-
Brulhart-Meynet MC, Braunersreuther V, Brinck J, et al. Improving reconstituted HDL composition for efficient postischemic reduction of ischemia reperfusion injury. PLoS One 2015; 10:e0119664.
-
(2015)
PLoS One
, vol.10
-
-
Brulhart-Meynet, M.C.1
Braunersreuther, V.2
Brinck, J.3
-
24
-
-
84905038899
-
Apolipoprotein M modulates erythrocyte efflux and tubular reabsorption of sphingosine-1-phosphate
-
Sutter I, Park R, Othman A, et al. Apolipoprotein M modulates erythrocyte efflux and tubular reabsorption of sphingosine-1-phosphate. J Lipid Res 2014; 55:1730-1737.
-
(2014)
J Lipid Res
, vol.55
, pp. 1730-1737
-
-
Sutter, I.1
Park, R.2
Othman, A.3
-
25
-
-
84942156134
-
Defects of high-density lipoproteins in coronary artery disease caused by low sphingosine-1-phosphate content: Correction by sphingosine-1-phosphate-loading
-
Sattler K, Grä ler M, Keul P, et al. Defects of high-density lipoproteins in coronary artery disease caused by low sphingosine-1-phosphate content: correction by sphingosine-1-phosphate-loading. J Am Coll Cardiol 2015; 66:1470-1485.
-
(2015)
J Am Coll Cardiol
, vol.66
, pp. 1470-1485
-
-
Sattler, K.1
Grä Ler, M.2
Keul, P.3
-
26
-
-
84919683044
-
Functionality of HDL: Antioxidation and detoxifying effects
-
Karlsson H, Kontush A, James RW. Functionality of HDL: antioxidation and detoxifying effects. Handb Exp Pharmacol 2015; 224:207-228.
-
(2015)
Handb Exp Pharmacol
, vol.224
, pp. 207-228
-
-
Karlsson, H.1
Kontush, A.2
James, R.W.3
-
27
-
-
84900532524
-
Intestinal lipid absorption and lipoprotein formation
-
Hussain MM. Intestinal lipid absorption and lipoprotein formation. Curr Opin Lipidol 2014; 25:200-206.
-
(2014)
Curr Opin Lipidol
, vol.25
, pp. 200-206
-
-
Hussain, M.M.1
-
28
-
-
84947983157
-
High density lipoprotein efficiently accepts surface but not internal oxidised lipids from oxidised low density lipoprotein
-
Rasmiena AA, Barlow CK, Ng TW, et al. High density lipoprotein efficiently accepts surface but not internal oxidised lipids from oxidised low density lipoprotein. Biochim Biophys Acta 2015; 1861: 69-77.
-
(2015)
Biochim Biophys Acta
, vol.1861
, pp. 69-77
-
-
Rasmiena, A.A.1
Barlow, C.K.2
Ng, T.W.3
-
29
-
-
84941331061
-
How HDL protects LDL against atherogenic modification: Paraoxonase 1 and other dramatis personae
-
Soran H, Schofield JD, Liu Y, Durrington PN. How HDL protects LDL against atherogenic modification: paraoxonase 1 and other dramatis personae. Curr Opin Lipidol 2015; 26:247-256.
-
(2015)
Curr Opin Lipidol
, vol.26
, pp. 247-256
-
-
Soran, H.1
Schofield, J.D.2
Liu, Y.3
Durrington, P.N.4
-
30
-
-
84958095360
-
High density lipoprotein modulates thrombosis by preventing von Willebrand factor self-association and subsequent platelet adhesion
-
Chung DW, Chen J, Ling M, et al. High density lipoprotein modulates thrombosis by preventing von Willebrand factor self-association and subsequent platelet adhesion. Blood 2016; 127:637-645.
-
(2016)
Blood
, vol.127
, pp. 637-645
-
-
Chung, D.W.1
Chen, J.2
Ling, M.3
-
31
-
-
84932166350
-
Reconstituted highdensity lipoprotein attenuates cholesterol crystal-induced inflammatory responses by reducing complement activation
-
Niyonzima N, Samstad EO, Aune MH, et al. Reconstituted highdensity lipoprotein attenuates cholesterol crystal-induced inflammatory responses by reducing complement activation. J Immunol 2015; 195:257-264.
-
(2015)
J Immunol
, vol.195
, pp. 257-264
-
-
Niyonzima, N.1
Samstad, E.O.2
Aune, M.H.3
-
32
-
-
84919629314
-
Structure of HDL: Particle subclasses and molecular components
-
Kontush A, Lindahl M, Lhomme M, et al. Structure of HDL: particle subclasses and molecular components. Handb Exp Pharmacol 2015; 224:3-51.
-
(2015)
Handb Exp Pharmacol
, vol.224
, pp. 3-51
-
-
Kontush, A.1
Lindahl, M.2
Lhomme, M.3
-
33
-
-
84959535692
-
Proteomic and lipidomic analyses of paraoxonase defined high density lipoprotein particles: Association of paraoxonase with the anticoagulant, protein S
-
Moren X, Lhomme M, Bulla A, et al. Proteomic and lipidomic analyses of paraoxonase defined high density lipoprotein particles: association of paraoxonase with the anticoagulant, protein S. Proteomics Clin Appl 2016; 10:230-238.
-
(2016)
Proteomics Clin Appl
, vol.10
, pp. 230-238
-
-
Moren, X.1
Lhomme, M.2
Bulla, A.3
-
34
-
-
79953301730
-
MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins
-
Vickers KC, Palmisano BT, Shoucri BM, et al. MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nat Cell Biol 2011; 13:423-433.
-
(2011)
Nat Cell Biol
, vol.13
, pp. 423-433
-
-
Vickers, K.C.1
Palmisano, B.T.2
Shoucri, B.M.3
-
35
-
-
84896894879
-
HDL-transferred microRNA-223 regulates ICAM-1 expression in endothelial cells
-
Tabet F, Vickers KC, Cuesta Torres LF, et al. HDL-transferred microRNA-223 regulates ICAM-1 expression in endothelial cells. Nat Commun 2014; 5:3292.
-
(2014)
Nat Commun
, vol.5
, pp. 3292
-
-
Tabet, F.1
Vickers, K.C.2
Cuesta Torres, L.F.3
-
36
-
-
84879109514
-
Characterization of levels and cellular transfer of circulating lipoprotein-bound microRNAs
-
Wagner J, Riwanto M, Besler C, et al. Characterization of levels and cellular transfer of circulating lipoprotein-bound microRNAs. Arterioscler Thromb Vasc Biol 2013; 33:1392-1400.
-
(2013)
Arterioscler Thromb Vasc Biol
, vol.33
, pp. 1392-1400
-
-
Wagner, J.1
Riwanto, M.2
Besler, C.3
-
37
-
-
84929957883
-
MicroRNA-mediated mechanisms of the cellular stress response in atherosclerosis
-
Schober A, Nazari-Jahantigh M, Weber C. MicroRNA-mediated mechanisms of the cellular stress response in atherosclerosis. Nat Rev Cardiol 2015; 12:361-374.
-
(2015)
Nat Rev Cardiol
, vol.12
, pp. 361-374
-
-
Schober, A.1
Nazari-Jahantigh, M.2
Weber, C.3
-
38
-
-
84884376382
-
HDL endocytosis and resecretion
-
Röhrl C, Stangl H. HDL endocytosis and resecretion. Biochim Biophys Acta 2013; 1831:1626-1633.
-
(2013)
Biochim Biophys Acta
, vol.1831
, pp. 1626-1633
-
-
Röhrl, C.1
Stangl, H.2
-
39
-
-
84912076009
-
Ecto-F1-ATPase/P2Y pathways in metabolic and vascular functions of high density lipoproteins
-
Martinez LO, Najib S, Perret B, et al. Ecto-F1-ATPase/P2Y pathways in metabolic and vascular functions of high density lipoproteins. Atherosclerosis 2015; 238:89-100.
-
(2015)
Atherosclerosis
, vol.238
, pp. 89-100
-
-
Martinez, L.O.1
Najib, S.2
Perret, B.3
-
40
-
-
84929085806
-
Increased atherosclerosis in P2Y13/apolipoprotein e double-knock-out mice: Contribution of P2Y13 to RCT
-
Lichtenstein L, Serhan N, Espinosa-Delgado S, et al. Increased atherosclerosis in P2Y13/apolipoprotein E double-knock-out mice: contribution of P2Y13 to RCT. Cardiovasc Res 2015; 106:314-323.
-
(2015)
Cardiovasc Res
, vol.106
, pp. 314-323
-
-
Lichtenstein, L.1
Serhan, N.2
Espinosa-Delgado, S.3
-
41
-
-
84883173427
-
Serum IF1 concentration is independently associated to HDL levels and to coronary heart disease: The GENES study
-
Genoux A, Ruidavets JB, Ferrières J, et al. Serum IF1 concentration is independently associated to HDL levels and to coronary heart disease: the GENES study. J Lipid Res 2013; 54:2550-2558.
-
(2013)
J Lipid Res
, vol.54
, pp. 2550-2558
-
-
Genoux, A.1
Ruidavets, J.B.2
Ferrières, J.3
-
42
-
-
84904966168
-
Cubilin maintains blood levels of HDL and albumin
-
Aseem O, Smith BT, Cooley MA, et al. Cubilin maintains blood levels of HDL and albumin. J Am Soc Nephrol 2014; 25:1028-1036.
-
(2014)
J Am Soc Nephrol
, vol.25
, pp. 1028-1036
-
-
Aseem, O.1
Smith, B.T.2
Cooley, M.A.3
-
44
-
-
84919632460
-
High-density lipoproteins in stroke
-
Meilhac O. High-density lipoproteins in stroke. Handb Exp Pharmacol 2015; 224:509-526.
-
(2015)
Handb Exp Pharmacol
, vol.224
, pp. 509-526
-
-
Meilhac, O.1
-
45
-
-
84928940302
-
Anti-inflammatory function of highdensity lipoproteins via autophagy of IkB kinase
-
Gerster R, Eloranta JJ, Hausmann M, et al. Anti-inflammatory function of highdensity lipoproteins via autophagy of IkB kinase. Cell Mol Gastroenterol Hepatol 2015; 1:171-187.
-
(2015)
Cell Mol Gastroenterol Hepatol
, vol.1
, pp. 171-187
-
-
Gerster, R.1
Eloranta, J.J.2
Hausmann, M.3
-
46
-
-
84941274459
-
Biogenesis and cytotoxicity of APOL1 renal risk variant proteins in hepatocytes and hepatoma cells
-
Cheng D, Weckerle A, Yu Y, et al. Biogenesis and cytotoxicity of APOL1 renal risk variant proteins in hepatocytes and hepatoma cells. J Lipid Res 2015; 56:1583-1593.
-
(2015)
J Lipid Res
, vol.56
, pp. 1583-1593
-
-
Cheng, D.1
Weckerle, A.2
Yu, Y.3
-
47
-
-
84951574144
-
Dysfunctional HDL and atherosclerotic cardiovascular disease
-
Rosenson RS, Brewer HB Jr, Ansell BJ, et al. Dysfunctional HDL and atherosclerotic cardiovascular disease. Nat Rev Cardiol 2016; 13:48-60.
-
(2016)
Nat Rev Cardiol
, vol.13
, pp. 48-60
-
-
Rosenson, R.S.1
Brewer, H.B.2
Ansell, B.J.3
-
48
-
-
84934995809
-
Plasmalogens of highdensity lipoproteins (HDL) are associated with coronary artery disease and antiapoptotic activity of HDL
-
Sutter I, Velagapudi S, Othman A, et al. Plasmalogens of highdensity lipoproteins (HDL) are associated with coronary artery disease and antiapoptotic activity of HDL. Atherosclerosis 2015; 241:539-546.
-
(2015)
Atherosclerosis
, vol.241
, pp. 539-546
-
-
Sutter, I.1
Velagapudi, S.2
Othman, A.3
-
49
-
-
79959919890
-
Mechanisms underlying adverse effects of HDL on eNOS-activating pathways in patients with coronary artery disease
-
Besler C, Heinrich K, Rohrer L, et al. Mechanisms underlying adverse effects of HDL on eNOS-activating pathways in patients with coronary artery disease. J Clin Invest 2011; 121:2693-2708.
-
(2011)
J Clin Invest
, vol.121
, pp. 2693-2708
-
-
Besler, C.1
Heinrich, K.2
Rohrer, L.3
-
50
-
-
84876780604
-
Abnormal high-density lipoprotein induces endothelial dysfunction via activation of Toll-like receptor-2
-
Speer T, Rohrer L, Blyszczuk P, et al. Abnormal high-density lipoprotein induces endothelial dysfunction via activation of Toll-like receptor-2. Immunity 2013; 38:754-768.
-
(2013)
Immunity
, vol.38
, pp. 754-768
-
-
Speer, T.1
Rohrer, L.2
Blyszczuk, P.3
-
51
-
-
84983119263
-
Serum amyloid A: High-density lipoproteins interaction and cardiovascular risk
-
Zewinger S, Drechsler C, Kleber ME, et al. Serum amyloid A: high-density lipoproteins interaction and cardiovascular risk. Eur Heart J 2015; 36:3007-3016.
-
(2015)
Eur Heart J
, vol.36
, pp. 3007-3016
-
-
Zewinger, S.1
Drechsler, C.2
Kleber, M.E.3
-
52
-
-
84888203299
-
Small, dense high-density lipoprotein-3 particles are enriched in negatively charged phospholipids: Relevance to cellular cholesterol efflux, antioxidative, antithrombotic, anti-inflammatory, and antiapoptotic functionalities
-
Camont L, Lhomme M, Rached F, et al. Small, dense high-density lipoprotein-3 particles are enriched in negatively charged phospholipids: relevance to cellular cholesterol efflux, antioxidative, antithrombotic, anti-inflammatory, and antiapoptotic functionalities. Arterioscler Thromb Vasc Biol 2013; 33:2715-2723.
-
(2013)
Arterioscler Thromb Vasc Biol
, vol.33
, pp. 2715-2723
-
-
Camont, L.1
Lhomme, M.2
Rached, F.3
-
53
-
-
84955635473
-
Niacin therapy increases highdensity lipoprotein particles and total cholesterol efflux capacity but not ABCA1-specific cholesterol efflux in statin-treated subjects
-
Ronsein GE, Hutchins PM, Isquith D, et al. Niacin therapy increases highdensity lipoprotein particles and total cholesterol efflux capacity but not ABCA1-specific cholesterol efflux in statin-treated subjects. Arterioscler Thromb Vasc Biol 2016; 36:404-411.
-
(2016)
Arterioscler Thromb Vasc Biol
, vol.36
, pp. 404-411
-
-
Ronsein, G.E.1
Hutchins, P.M.2
Isquith, D.3
-
54
-
-
84946550481
-
HDL-apolipoprotein A-I exchange is independently associated with cholesterol efflux capacity
-
Borja MS, Ng KF, Irwin A, et al. HDL-apolipoprotein A-I exchange is independently associated with cholesterol efflux capacity. J Lipid Res 2015; 56:2002-2009.
-
(2015)
J Lipid Res
, vol.56
, pp. 2002-2009
-
-
Borja, M.S.1
Ng, K.F.2
Irwin, A.3
-
55
-
-
84933060189
-
High-density lipoprotein (HDL) phospholipid content and cholesterol efflux capacity are reduced in patients with very high HDL cholesterol and coronary disease
-
Agarwala AP, Rodrigues A, Risman M, et al. High-density lipoprotein (HDL) phospholipid content and cholesterol efflux capacity are reduced in patients with very high HDL cholesterol and coronary disease. Arterioscler Thromb Vasc Biol 2015; 35:1515-1519.
-
(2015)
Arterioscler Thromb Vasc Biol
, vol.35
, pp. 1515-1519
-
-
Agarwala, A.P.1
Rodrigues, A.2
Risman, M.3
-
56
-
-
12844268120
-
Localization of nitration and chlorination sites on apolipoprotein A-I catalyzed by myeloperoxidase in human atheroma and associated oxidative impairment in ABCA1-dependent cholesterol efflux from macrophages
-
Zheng L, Settle M, Brubaker G, et al. Localization of nitration and chlorination sites on apolipoprotein A-I catalyzed by myeloperoxidase in human atheroma and associated oxidative impairment in ABCA1-dependent cholesterol efflux from macrophages. J Biol Chem 2005; 280:38-47.
-
(2005)
J Biol Chem
, vol.280
, pp. 38-47
-
-
Zheng, L.1
Settle, M.2
Brubaker, G.3
-
57
-
-
84893772037
-
An abundant dysfunctional apolipoprotein A1 in human atheroma
-
Huang Y, DiDonato JA, Levison BS, et al. An abundant dysfunctional apolipoprotein A1 in human atheroma. Nat Med 2014; 20:193-203.
-
(2014)
Nat Med
, vol.20
, pp. 193-203
-
-
Huang, Y.1
DiDonato, J.A.2
Levison, B.S.3
-
58
-
-
84897403739
-
Effects of native and myeloperoxidase-modified apolipoprotein a-I on reverse cholesterol transport and atherosclerosis in mice
-
Hewing B, Parathath S, Barrett T, et al. Effects of native and myeloperoxidase-modified apolipoprotein a-I on reverse cholesterol transport and atherosclerosis in mice. Arterioscler Thromb Vasc Biol 2014; 34:779-789.
-
(2014)
Arterioscler Thromb Vasc Biol
, vol.34
, pp. 779-789
-
-
Hewing, B.1
Parathath, S.2
Barrett, T.3
-
59
-
-
84941308579
-
Inflammatory remodeling of the HDL proteome impairs cholesterol efflux capacity
-
Vaisar T, Tang C, Babenko I, et al. Inflammatory remodeling of the HDL proteome impairs cholesterol efflux capacity. J Lipid Res 2015; 56:1519-1530.
-
(2015)
J Lipid Res
, vol.56
, pp. 1519-1530
-
-
Vaisar, T.1
Tang, C.2
Babenko, I.3
-
60
-
-
84956609542
-
Serum amyloid A impairs the antiinflammatory properties of HDL
-
Han CY, Tang C, Guevara ME, et al. Serum amyloid A impairs the antiinflammatory properties of HDL. J Clin Invest 2016; 126:796.
-
(2016)
J Clin Invest
, vol.126
, pp. 796
-
-
Han, C.Y.1
Tang, C.2
Guevara, M.E.3
-
61
-
-
84890937156
-
High-density lipoprotein cholesterol, coronary artery disease, and cardiovascular mortality
-
Silbernagel G, Schöttker B, Appelbaum S, et al. High-density lipoprotein cholesterol, coronary artery disease, and cardiovascular mortality. Eur Heart J 2013; 34:3563-3571.
-
(2013)
Eur Heart J
, vol.34
, pp. 3563-3571
-
-
Silbernagel, G.1
Schöttker, B.2
Appelbaum, S.3
-
62
-
-
84870045994
-
Effects of dalcetrapib in patients with a recent acute coronary syndrome
-
Schwartz GG, Olsson AG, Abt M, Wright RS, et al., dal-OUTCOMES Investigators. Effects of dalcetrapib in patients with a recent acute coronary syndrome. N Engl J Med 2012; 367:2089-2099.
-
(2012)
N Engl J Med
, vol.367
, pp. 2089-2099
-
-
Schwartz, G.G.1
Olsson, A.G.2
Abt, M.3
Wright, R.S.4
-
63
-
-
84955692142
-
Association of serum lipids and coronary heart disease in contemporary observational studies
-
Colantonio LD, Bittner V, Reynolds K, et al. Association of serum lipids and coronary heart disease in contemporary observational studies. Circulation 2016; 133:256-264.
-
(2016)
Circulation
, vol.133
, pp. 256-264
-
-
Colantonio, L.D.1
Bittner, V.2
Reynolds, K.3
-
64
-
-
77952993866
-
Seven direct methods for measuring HDL and LDL cholesterol compared with ultracentrifugation reference measurement procedures
-
Miller WG, Myers GL, Sakurabayashi I, et al. Seven direct methods for measuring HDL and LDL cholesterol compared with ultracentrifugation reference measurement procedures. Clin Chem 2010; 56:977-986.
-
(2010)
Clin Chem
, vol.56
, pp. 977-986
-
-
Miller, W.G.1
Myers, G.L.2
Sakurabayashi, I.3
-
65
-
-
84893878053
-
Clinical impact of direct HDLc and LDLc method bias in hypertriglyceridemia. A simulation study of the EAS-EFLM Collaborative Project Group
-
Langlois MR, Descamps OS, van der Laarse A, et al., EAS-EFLM Collaborative Project. Clinical impact of direct HDLc and LDLc method bias in hypertriglyceridemia. A simulation study of the EAS-EFLM Collaborative Project Group. Atherosclerosis 2014; 233:83-90.
-
(2014)
Atherosclerosis
, vol.233
, pp. 83-90
-
-
EAS-EFLM Collaborative Project1
Langlois, M.R.2
Descamps, O.S.3
Van Der Laarse, A.4
-
66
-
-
85048354213
-
J.C. Fruchart combination lipid therapy in type 2 diabetes
-
Sacks FM, Carey VJ. J.C. Fruchart Combination lipid therapy in type 2 diabetes. N Engl J Med 2010; 363:692-694.
-
(2010)
N Engl J Med
, vol.363
, pp. 692-694
-
-
Sacks, F.M.1
Carey, V.J.2
-
67
-
-
84928798085
-
Pharmacogenomic determinants of the cardiovascular effects of dalcetrapib
-
Tardif JC, Rheaume E, Lemieux Perreault LP, et al. Pharmacogenomic determinants of the cardiovascular effects of dalcetrapib. Circ Cardiovasc Genet 2015; 8:372-382.
-
(2015)
Circ Cardiovasc Genet
, vol.8
, pp. 372-382
-
-
Tardif, J.C.1
Rheaume, E.2
Lemieux Perreault, L.P.3
-
68
-
-
84868552674
-
Will cholesteryl ester transfer protein inhibition succeed primarily by lowering low-density lipoprotein cholesterol? Insights from human genetics and clinical trials
-
Kathiresan S. Will cholesteryl ester transfer protein inhibition succeed primarily by lowering low-density lipoprotein cholesterol? Insights from human genetics and clinical trials. J Am Coll Cardiol 2012; 60:2049-2052.
-
(2012)
J Am Coll Cardiol
, vol.60
, pp. 2049-2052
-
-
Kathiresan, S.1
-
69
-
-
84924606733
-
Circulating cholesteryl ester transfer protein and coronary heart disease: Mendelian randomization meta-analysis
-
Niu W, Qi Y. Circulating cholesteryl ester transfer protein and coronary heart disease: mendelian randomization meta-analysis. Circ Cardiovasc Genet 2015; 8:114-121.
-
(2015)
Circ Cardiovasc Genet
, vol.8
, pp. 114-121
-
-
Niu, W.1
Qi, Y.2
-
70
-
-
84966498403
-
-
(Accessed 28 December 2015)
-
https://investor.lilly.com/releasedetail.cfm?ReleaseID=936130. (Accessed 28 December 2015)
-
-
-
-
71
-
-
84942761786
-
HDL cholesterol and stroke risk: The multi-ethnic study of atherosclerosis
-
Reina SA, Llabre MM, Allison MA, et al. HDL cholesterol and stroke risk: the multi-ethnic study of atherosclerosis. Atherosclerosis 2015; 243:314-319.
-
(2015)
Atherosclerosis
, vol.243
, pp. 314-319
-
-
Reina, S.A.1
Llabre, M.M.2
Allison, M.A.3
-
72
-
-
84931291700
-
ApoA-I/HDL-C levels are inversely associated with abdominal aortic aneurysm progression
-
Burillo E, Lindholt JS, Molina-Sánchez P, et al. ApoA-I/HDL-C levels are inversely associated with abdominal aortic aneurysm progression. Thromb Haemost 2015; 113:1335-1346.
-
(2015)
Thromb Haemost
, vol.113
, pp. 1335-1346
-
-
Burillo, E.1
Lindholt, J.S.2
Molina-Sánchez, P.3
-
74
-
-
84946509188
-
Using genetic variants to assess the relationship between circulating lipids and type 2 diabetes
-
GENESIS Consortium. Fall T, Xie W, Poon W, et al. Using genetic variants to assess the relationship between circulating lipids and type 2 diabetes. Diabetes 2015; 64:2676-2684.
-
(2015)
Diabetes
, vol.64
, pp. 2676-2684
-
-
GENESIS Consortium1
Fall, T.2
Xie, W.3
Poon, W.4
-
75
-
-
84953286690
-
Serum lipids and breast cancer risk: A meta-analysis of prospective cohort studies
-
Ni H, Liu H, Gao R. Serum lipids and breast cancer risk: a meta-analysis of prospective cohort studies. PLoS One 2015; 10:e0142669.
-
(2015)
PLoS One
, vol.10
-
-
Ni, H.1
Liu, H.2
Gao, R.3
-
76
-
-
79960301171
-
Blood lipid and lipoprotein concentrations and colorectal cancer risk in the European Prospective Investigation into Cancer and Nutrition
-
van Duijnhoven FJ, Bueno-De-Mesquita HB, Calligaro M, et al. Blood lipid and lipoprotein concentrations and colorectal cancer risk in the European Prospective Investigation into Cancer and Nutrition. Gut 2011; 60:1094-1102.
-
(2011)
Gut
, vol.60
, pp. 1094-1102
-
-
Van Duijnhoven, F.J.1
Bueno-De-Mesquita, H.B.2
Calligaro, M.3
-
78
-
-
84941340935
-
Cross sectional and longitudinal associations between cardiovascular risk factors and age related macular degeneration in the EPIC-Norfolk eye study
-
Yip JL, Khawaja AP, Chan MP, et al. Cross sectional and longitudinal associations between cardiovascular risk factors and age related macular degeneration in the EPIC-Norfolk eye study. PLoS One 2015; 10:e0132565.
-
(2015)
PLoS One
, vol.10
-
-
Yip, J.L.1
Khawaja, A.P.2
Chan, M.P.3
-
79
-
-
84955057955
-
New loci and coding variants confer risk for age-related macular degeneration in East Asians
-
Cheng CY, Yamashiro K, Chen LJ, et al. New loci and coding variants confer risk for age-related macular degeneration in East Asians. Nat Commun 2015; 6:6063.
-
(2015)
Nat Commun
, vol.6
, pp. 6063
-
-
Cheng, C.Y.1
Yamashiro, K.2
Chen, L.J.3
-
80
-
-
33847327365
-
Benchmarks for the assessment of novel cardiovascular biomarkers
-
Morrow DA, de Lemos JA. Benchmarks for the assessment of novel cardiovascular biomarkers. Circulation 2007; 115:949-952.
-
(2007)
Circulation
, vol.115
, pp. 949-952
-
-
Morrow, D.A.1
De Lemos, J.A.2
-
81
-
-
33745004785
-
Biomarkers of cardiovascular disease: Molecular basis and practical considerations
-
Vasan RS. Biomarkers of cardiovascular disease: molecular basis and practical considerations. Circulation 2006; 113:2335-2362.
-
(2006)
Circulation
, vol.113
, pp. 2335-2362
-
-
Vasan, R.S.1
-
82
-
-
79952222810
-
HDL measures, particle heterogeneity, proposed nomenclature, and relation to atherosclerotic cardiovascular events
-
Rosenson RS, Brewer HB Jr, Chapman MJ, et al. HDL measures, particle heterogeneity, proposed nomenclature, and relation to atherosclerotic cardiovascular events. Clin Chem 2011; 57:392-410.
-
(2011)
Clin Chem
, vol.57
, pp. 392-410
-
-
Rosenson, R.S.1
Brewer, H.B.2
Chapman, M.J.3
-
83
-
-
84949672279
-
HDL particle number and size as predictors of cardiovascular disease
-
Kontush A. HDL particle number and size as predictors of cardiovascular disease. Front Pharmacol 2015; 6:218.
-
(2015)
Front Pharmacol
, vol.6
, pp. 218
-
-
Kontush, A.1
-
84
-
-
35248829949
-
Lipoprotein particles, insulin, adiponectin, C-reactive protein and risk of coronary heart disease among men with metabolic syndrome
-
Kuller LH, Grandits G, Cohen JD, et al., Multiple Risk Factor Intervention Trial Research Group. Lipoprotein particles, insulin, adiponectin, C-reactive protein and risk of coronary heart disease among men with metabolic syndrome. Atherosclerosis 2007; 195:122-128.
-
(2007)
Atherosclerosis
, vol.195
, pp. 122-128
-
-
Kuller, L.H.1
Grandits, G.2
Cohen, J.D.3
-
85
-
-
84864767131
-
High-density lipoprotein cholesterol and particle concentrations, carotid atherosclerosis, and coronary events: MESA (multiethnic study of atherosclerosis)
-
Mackey RH, Greenland P, Goff DC Jr, et al. High-density lipoprotein cholesterol and particle concentrations, carotid atherosclerosis, and coronary events: MESA (multiethnic study of atherosclerosis). J Am Coll Cardiol 2012; 60:508-516.
-
(2012)
J Am Coll Cardiol
, vol.60
, pp. 508-516
-
-
Mackey, R.H.1
Greenland, P.2
Goff, D.C.3
-
86
-
-
85027952408
-
Relation of black race between high density lipoprotein cholesterol content, high density lipoprotein particles and coronary events (from the Dallas Heart Study)
-
Chandra A, Neeland IJ, Das SR, et al. Relation of black race between high density lipoprotein cholesterol content, high density lipoprotein particles and coronary events (from the Dallas Heart Study). Am J Cardiol 2015; 115:890-894.
-
(2015)
Am J Cardiol
, vol.115
, pp. 890-894
-
-
Chandra, A.1
Neeland, I.J.2
Das, S.R.3
-
87
-
-
84884322622
-
High-density lipoprotein cholesterol, size, particle number, and residual vascular risk after potent statin therapy
-
Mora S, Glynn RJ, Ridker PM. High-density lipoprotein cholesterol, size, particle number, and residual vascular risk after potent statin therapy. Circulation 2013; 128:1189-1197.
-
(2013)
Circulation
, vol.128
, pp. 1189-1197
-
-
Mora, S.1
Glynn, R.J.2
Ridker, P.M.3
-
88
-
-
61849110301
-
Lipoprotein particle profiles by nuclear magnetic resonance compared with standard lipids and apolipoproteins in predicting incident cardiovascular disease in women
-
Mora S, Otvos JD, Rifai N, et al. Lipoprotein particle profiles by nuclear magnetic resonance compared with standard lipids and apolipoproteins in predicting incident cardiovascular disease in women. Circulation 2009; 119:931-939.
-
(2009)
Circulation
, vol.119
, pp. 931-939
-
-
Mora, S.1
Otvos, J.D.2
Rifai, N.3
-
89
-
-
84921628667
-
Cholesterol-overloaded HDL particles are independently associated with progression of carotid atherosclerosis in a cardiovascular disease-free population: A community-based cohort study
-
Qi Y, Fan J, Liu J, et al. Cholesterol-overloaded HDL particles are independently associated with progression of carotid atherosclerosis in a cardiovascular disease-free population: a community-based cohort study. J Am Coll Cardiol 2015; 65:355-363.
-
(2015)
J Am Coll Cardiol
, vol.65
, pp. 355-363
-
-
Qi, Y.1
Fan, J.2
Liu, J.3
-
90
-
-
58749094271
-
High-density lipoprotein particle size and concentration and coronary risk
-
El Harchaoui K, Arsenault BJ, Franssen R, et al. High-density lipoprotein particle size and concentration and coronary risk. Ann Intern Med 2009; 150:84-93.
-
(2009)
Ann Intern Med
, vol.150
, pp. 84-93
-
-
El Harchaoui, K.1
Arsenault, B.J.2
Franssen, R.3
-
91
-
-
84922062274
-
Use of lipoprotein particle measures for assessing coronary heart disease risk post-American Heart Association/ American College of Cardiology guidelines: The multi-ethnic study of atherosclerosis
-
Steffen BT, Guan W, Remaley AT, et al. Use of lipoprotein particle measures for assessing coronary heart disease risk post-American Heart Association/ American College of Cardiology guidelines: the multi-ethnic study of atherosclerosis. Arterioscler Thromb Vasc Biol 2015; 35:448-454.
-
(2015)
Arterioscler Thromb Vasc Biol
, vol.35
, pp. 448-454
-
-
Steffen, B.T.1
Guan, W.2
Remaley, A.T.3
-
92
-
-
84949462326
-
Atherogenic lipoprotein subfractions determined by ion mobility and first cardiovascular events after random allocation to high-intensity statin or placebo: The justification for the use of statins in prevention: An intervention trial evaluating rosuvastatin (JUPITER) trial
-
Mora S, Caulfield MP, Wohlgemuth J, et al. Atherogenic lipoprotein subfractions determined by ion mobility and first cardiovascular events after random allocation to high-intensity statin or placebo: the justification for the use of statins in prevention: an intervention trial evaluating rosuvastatin (JUPITER) trial. Circulation 2015; 132:2220-2229.
-
(2015)
Circulation
, vol.132
, pp. 2220-2229
-
-
Mora, S.1
Caulfield, M.P.2
Wohlgemuth, J.3
-
93
-
-
84925310644
-
Liposcale: A novel advanced lipoprotein test based on 2D diffusion-ordered 1H NMR spectroscopy
-
Mallol R, AmigóN, Rodríguez MA, et al. Liposcale: a novel advanced lipoprotein test based on 2D diffusion-ordered 1H NMR spectroscopy. J Lipid Res 2015; 56:737-746.
-
(2015)
J Lipid Res
, vol.56
, pp. 737-746
-
-
Mallol, R.1
Amigó, N.2
Rodríguez, M.A.3
-
94
-
-
79251617578
-
Large-scale candidate gene analysis of HDL particle features
-
Kaess BM, Tomaszewski M, Braund PS, et al. Large-scale candidate gene analysis of HDL particle features. PLoS One 2011; 6:e14529.
-
(2011)
PLoS One
, vol.6
-
-
Kaess, B.M.1
Tomaszewski, M.2
Braund, P.S.3
-
95
-
-
84864384899
-
High-throughput quantification of circulating metabolites improves prediction of subclinical atherosclerosis
-
Würtz P, Raiko JR, Magnussen CG, et al. High-throughput quantification of circulating metabolites improves prediction of subclinical atherosclerosis. Eur Heart J 2012; 33:2307-2316.
-
(2012)
Eur Heart J
, vol.33
, pp. 2307-2316
-
-
Würtz, P.1
Raiko, J.R.2
Magnussen, C.G.3
-
96
-
-
78651379500
-
Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis
-
Khera AV, Cuchel M, de la Llera-Moya M, et al. Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis. N Engl J Med 2011; 364:127-135.
-
(2011)
N Engl J Med
, vol.364
, pp. 127-135
-
-
Khera, A.V.1
Cuchel, M.2
De La Llera-Moya, M.3
-
97
-
-
84919343998
-
HDL-C efflux capacity and incident cardiovascular events
-
Rohatgi A, Khera A, Berry JD, et al. HDL-C efflux capacity and incident cardiovascular events. N Engl J Med 2014; 371:2383-2393.
-
(2014)
N Engl J Med
, vol.371
, pp. 2383-2393
-
-
Rohatgi, A.1
Khera, A.2
Berry, J.D.3
-
98
-
-
84934992975
-
Reproducibility and biological variability of HDL's vascular functional assays
-
O'Neill F, McLoughlin E, Riwanto M, et al. Reproducibility and biological variability of HDL's vascular functional assays. Atherosclerosis 2015; 241:588-594.
-
(2015)
Atherosclerosis
, vol.241
, pp. 588-594
-
-
O'Neill, F.1
McLoughlin, E.2
Riwanto, M.3
-
99
-
-
84928978981
-
HDL cholesterol efflux capacity and cardiovascular events
-
Ritsch A, Scharnagl H, Mä rz W. HDL cholesterol efflux capacity and cardiovascular events. N Engl J Med 2015; 372:1870-1871.
-
(2015)
N Engl J Med
, vol.372
, pp. 1870-1871
-
-
Ritsch, A.1
Scharnagl, H.2
Mä Rz, W.3
-
100
-
-
84934437744
-
Association of HDL cholesterol efflux capacity with incident coronary heart disease events: A prospective casecontrol study
-
Saleheen D, Scott R, Javad S, et al. Association of HDL cholesterol efflux capacity with incident coronary heart disease events: a prospective casecontrol study. Lancet Diabetes Endocrinol 2015; 3:507-513.
-
(2015)
Lancet Diabetes Endocrinol
, vol.3
, pp. 507-513
-
-
Saleheen, D.1
Scott, R.2
Javad, S.3
-
101
-
-
84879113852
-
Paradoxical association of enhanced cholesterol efflux with increased incident cardiovascular risks
-
Li XM, Tang WH, Mosior MK, et al. Paradoxical association of enhanced cholesterol efflux with increased incident cardiovascular risks. Arterioscler Thromb Vasc Biol 2013; 33:1696-1705.
-
(2013)
Arterioscler Thromb Vasc Biol
, vol.33
, pp. 1696-1705
-
-
Li, X.M.1
Tang, W.H.2
Mosior, M.K.3
-
102
-
-
84970938018
-
HDL-C efflux predicts graft failure in renal transplant recipients
-
Annema W, Dikkers A, de Boer JF, et al. HDL-C efflux predicts graft failure in renal transplant recipients. J Am Soc Nephrol 2016; 27:595-603.
-
(2016)
J Am Soc Nephrol
, vol.27
, pp. 595-603
-
-
Annema, W.1
Dikkers, A.2
De Boer, J.F.3
-
103
-
-
84946763626
-
Cholesterol efflux capacity and prebeta-1 HDL concentrations are increased in dyslipidemic patients treated with evacetrapib
-
Nicholls SJ, Ruotolo G, Brewer HB, et al. Cholesterol efflux capacity and prebeta-1 HDL concentrations are increased in dyslipidemic patients treated with evacetrapib. J Am Coll Cardiol 2015; 66:2201-2210.
-
(2015)
J Am Coll Cardiol
, vol.66
, pp. 2201-2210
-
-
Nicholls, S.J.1
Ruotolo, G.2
Brewer, H.B.3
-
104
-
-
84863403878
-
Effect of dalcetrapib plus pravastatin on lipoprotein metabolism and high-density lipoprotein composition and function in dyslipidemic patients: Results of a phase IIb dose-ranging study
-
Ballantyne CM, Miller M, Niesor EJ, et al. Effect of dalcetrapib plus pravastatin on lipoprotein metabolism and high-density lipoprotein composition and function in dyslipidemic patients: results of a phase IIb dose-ranging study. Am Heart J 2012; 163:515-552.
-
(2012)
Am Heart J
, vol.163
, pp. 515-552
-
-
Ballantyne, C.M.1
Miller, M.2
Niesor, E.J.3
-
105
-
-
84937576266
-
Excessive centrifugal fields damage high density lipoprotein
-
Munroe WH, Phillips ML, Schumaker VN. Excessive centrifugal fields damage high density lipoprotein. J Lipid Res 2015; 56:1172-1181.
-
(2015)
J Lipid Res
, vol.56
, pp. 1172-1181
-
-
Munroe, W.H.1
Phillips, M.L.2
Schumaker, V.N.3
-
106
-
-
84938070383
-
The risk of cardiovascular events with increased apolipoprotein CIII: A systematic review and metaanalysis
-
Wyler von Ballmoos MC, Haring B, Sacks FM. The risk of cardiovascular events with increased apolipoprotein CIII: A systematic review and metaanalysis. J Clin Lipidol 2015; 9:498-510.
-
(2015)
J Clin Lipidol
, vol.9
, pp. 498-510
-
-
Wyler Von Ballmoos, M.C.1
Haring, B.2
Sacks, F.M.3
-
107
-
-
84923766304
-
Quantification of HDL proteins, cardiac events, and mortality in patients with type 2 diabetes on hemodialysis
-
Kopecky C, Genser B, Drechsler C, et al. Quantification of HDL proteins, cardiac events, and mortality in patients with type 2 diabetes on hemodialysis. Clin J Am Soc Nephrol 2015; 10:224-231.
-
(2015)
Clin J Am Soc Nephrol
, vol.10
, pp. 224-231
-
-
Kopecky, C.1
Genser, B.2
Drechsler, C.3
-
108
-
-
84924003801
-
HDL cholesterol, apolipoproteins, and cardiovascular risk in hemodialysis patients
-
Silbernagel G, Genser B, Drechsler C, et al. HDL cholesterol, apolipoproteins, and cardiovascular risk in hemodialysis patients. J Am Soc Nephrol 2015; 26:484-492.
-
(2015)
J Am Soc Nephrol
, vol.26
, pp. 484-492
-
-
Silbernagel, G.1
Genser, B.2
Drechsler, C.3
|